BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2804809
Number of visits today
1080
Number of downloads
2057907
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Albhaisi S, Sanyal AJ. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. Front Endocrinol (Lausanne) 2021;12:665987. [PMID: 34040583 DOI: 10.3389/fendo.2021.665987] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Amin MA, Ragab HM, Abd El Maksoud N, Elaziz WA. CD24 Gene Expression as a Risk Factor for Non-Alcoholic Fatty Liver Disease. Diagnostics (Basel) 2023;13. [PMID: 36900128 DOI: 10.3390/diagnostics13050984] [Reference Citation Analysis]
2 Chen T, Dalton G, Oh SH, Maeso-Diaz R, Du K, Meyers RA, Guy C, Abdelmalek MF, Henao R, Guarnieri P, Pullen SS, Gregory S, Locker J, Brown JM, Diehl AM. Hepatocyte Smoothened Activity Controls Susceptibility to Insulin Resistance and Nonalcoholic Fatty Liver Disease. Cell Mol Gastroenterol Hepatol 2023;15:949-70. [PMID: 36535507 DOI: 10.1016/j.jcmgh.2022.12.008] [Reference Citation Analysis]
3 Smirnova E, Muthiah MD, Narayan N, Siddiqui MS, Puri P, Luketic VA, Contos MJ, Idowu M, Chuang JC, Billin AN, Huss RS, Myers RP, Boyett S, Seneshaw M, Min HK, Mirshahi F, Sanyal AJ. Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD. Hepatology 2022;76:1811-24. [PMID: 35561146 DOI: 10.1002/hep.32568] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Hu W, Lazar MA. Modelling metabolic diseases and drug response using stem cells and organoids. Nat Rev Endocrinol 2022. [PMID: 36071283 DOI: 10.1038/s41574-022-00733-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Li YM, Zhao SY, Zhao HH, Wang BH, Li SM. Procyanidin B2 Alleviates Palmitic Acid-Induced Injury in HepG2 Cells via Endoplasmic Reticulum Stress Pathway. Evid Based Complement Alternat Med 2021;2021:8920757. [PMID: 34956386 DOI: 10.1155/2021/8920757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345